AN OVERVIEW OF DRUG INFORMATION CENTER – FUNCTIONS AND CHALLENGES IN INDIA

  • THIREESHA P Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.
  • MOUNIKA K Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.
  • PRAMOD KUMAR ADUSUMILLI Department of Pharmacy Practice, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.
  • SRI HARSHA C Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.

Abstract

Drug information has been providing data on drugs that are being used in the health-care system. It also bears dosing, adverse drug reactions (ADRs), side effects, pharmacokinetic parameters and educating the health-care professionals and managing drug shortage, identifying alternative treatments, and developing alternative protocols for restrictive use. The Moto of drug information is to contribute genuine, precise, appropriate, impartial drug information to the patients, nursing staff, practicing physician, pharmacist, and other health-care professional. Drug information regularly responds to inquiries from patients, health-care professionals. The drug information center routinely receives queries from hospital staff, patients, and responds to queries regarding ADRs, drug interactions, pharmacokinetic parameters of drugs, and information on new drugs available in the market. Drug information services help in improving patient safety, minimizing drug-related issues to the patient, and rational use of drugs by both physician and patient. Drug information services are providing unambiguous data with a well-trained and registered clinical pharmacist. Most of the developed countries are using this service successfully. In well-developed countries, these centers provide accurate and up to date drug information to health-care professionals within minutes. However, developing countries like India need to pay more attention to the services. Information present in this paper not only enlightens the drug information services but also on the future aspects that need to be taken.

Keywords: Drug information services, Drug-related queries, Clinical pharmacy, Hospital pharmacist

References

1. Chauhan NS, Firdous, Raveendra R. Drug information center (DIC)-An Indian scenario. Indian J Pharm Pract 2009;1:21-2.
2. Vernon GM, Woods DJ. Development of an international network of drug information center. Aust J Hosp Pharm 1998;28:115-6.
3. Amerson AB. Drug information centers: An overview. Drug Inf J 1986;20:173-8.
4. Watanbe AS, McCart G, Shimomura S. Systematic approach to drug information requests. Am J Hosp Pharm 1975;32:1282-5.
5. Grimshaw JG, Russell IT. Effect of clinical guidelines on medical practice. A systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
6. Parker PF. The university of Kentucky drug information center. Am J Hosp Pharm 1965;22:427.
7. Rosenberg JM, Fuentes RJ, Starr CH, Kirschenbaum HL, McGuire H. Pharmacist-operated drug information centers in the United states. Am J Health Syst Pharm 1995;52:991-6.
8. Lakshmi PK, Rao DA. Drug information services to doctors of Karnataka. Indian J Pharmacol 2003;35:245-7.
9. Merritt GJ, Garnett WR. Analysis of a Hospital-based drug information center. Am J Hosp Pharm 1977;34:42-6.
10. Lat MI, Pizzol TD. User’s satisfaction in a Brazilian drug information center: Evaluation under a new approach. Lat Am J Pharm 2004;364:295-300.
11. Ming MW, Heba A, Ahmed A, Nahla HK, Yasmin HE. Quality evaluation and survey of the essential need for drug information centers. Int J Pharm Pharm Sci 2016;8:137-43.
12. Godlee F, Pakenham. Can we achieve health information for all by 2015? Lancet 2004;364:295-300.
13. Narhi U, Helakorpi S. Sources of medicine information in Finland. Health Pol 2007;84:51-7.
14. Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: Should it be disease or medication specific. Results of a community survey. Aust N Z J Public Health 2001;25:564-70.
15. Sleath B, Wurst K, Lowery T. Drug information sources and anti-depressant adherence. Commun Ment Health J 2003;39:359-68.
16. Kalra M, Pakhale SP. Drug information centers-need of the hour. Int J Pharm Sci 2011;1:69-79.
17. Bigdeli M, David H. Medicines in Health Systems Development: Advancing, Access, Affordability and Appropriate Use. Geneva: World Health Organization; 2011.
18. Davies DM, Ashton CH. Comprehensive clinical drug information service: First year’s experience. Br Med J 1977;1:89-90.
19. Rajanandh MG, Ruby V, Ramasamy C. Assessment of drug information services in a south Indian tertiary care hospital in Kanchipuram district. Int J Pharm Pharm Sci 2011;3:273-6.
20. Allison C, Bernkno PF. Drug information: From education to practice. Pharmacotherapy 2009;29:331-46.
21. Ball DE. Drug information in Zimbabwe: 1990-1999. Pharm World Sci 2007;29:131-6.
22. American Society of Health-System Pharmacists. ASHP Accreditation Standards for Postgraduate Year One (PGY1) Pharmacy Residency Programs; 2013. Available from: http://www.ashp.org/doclibrary/ accreditation/ASDPGY1-standard.aspx.
23. Venkatraghavan S, Rama M, Leelavathi DA. Performance of a drug information center in a South Indian teaching hospital. Int J Pharm Tech Res 2010;2:390-403.
24. Davies DM, Ashton CH, Rao JG, Rawlins MD, Routledge PA, Savage RL. Comprehensive clinical drug information service: First year’s experience. Br Med J 1977;1:89-90.
25. American Society of Health-System Pharmacists. ASHP Accreditation Standards for Postgraduate Year Two (PGY2) Pharmacy Residency Programs; 2013. Available from: http://www.ashp.org/doclibrary/ accreditation/ASDPGY2-standard.aspx.
26. Rosenberg JM, Schilit S, Nathan JP. Update on the status of 89 drug information centers in the United States. Am J Health Syst Pharm 2009;66:1718-22.
27. Powell L, Pepper M. Reviewing the pharmacy department’s drug information activities. Am J Health Syst Pharm 2000;57:2260-1.
28. Fox ER, Birt A, James KB. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm 2009;66:1399-1406.
29. Wisniewski CS, Robert S, Ball S. Collaboration between a drug information center and an academic detailing program. Am J Health Syst Pharm 2014;71:128-33.
30. Wang F, Troutman WG. Drug information education in doctor of pharmacy programs. Am J Pharm Educ 2006;70:51.
31. Umashankar MS. Review on benefits of drug information center services: A new transpiring practice to health care professionals in hospitals. J Chem Pharm Res 2017;9:28-38.
32. Patrick M, Meghan J. Drug Information: A Guide for Pharmacists. 5th ed. McGraw: Hill Education Publishers; 2016.
33. Pradhan SC. The performance of drug information center at the university of Kansas medical center Kansas city, USA-Experiences and evaluation. Ind J Pharm 2002;34:123-9.
34. Jyothi NV, Bharathi DR, Prakruthi GM. Evaluation of drug-drug interactions in patients of general medicine, ICU and Emergency departments at a tertiary care hospital. Int J Curr Pharm Res 2018;10:1.
35. Gong SD, Millares M, Van Riper KB. Drug information pharmacists at health-care facilities, universities and pharmaceutical companies. Am J Hosp Pharm 1992;49:1121-30.
36. Lakshmi PK, Bhaskaran S, Devi SG. Drug information services in India. Int Pharm J 2005;19:269.
37. Hanoi University of Pharmacy. The National Centre of Drug Information and Adverse Drug Reactions Monitoring 2009.
38. Health Systems Development Essential Drugs and Medicines, Drug Information Centers; 2011. Available from: http://www.whoindia.org/ en/section2/section 427-1396.
39. World Health Organization. WHO Collaborating Center for International Drug Monitoring. Uppsala Sweden: World Health Organization; 2011. Available from: http://www.who-umc.org.
40. Kalra M. Drug information centers need of the hour. Int Pharm Sci2011;1:69.
41. Joshi MP. University hospital-based drug information service in a developing country. Eur J Clin Pharmacol 1997;53:89-94.
42. Gitanjali B. Opportunities and challenges in conducting medical research in India: Food for thought. J Pharmacol Pharmacother 2011;2:71-3.
43. Lall SB, Peshin SS. Role and functions of poisons information center. Indian J Pediatr 1997;64:443-9.
44. Kshirsagar NA, Bachhav SS. Clinical pharmacology training in India: Status and need. Ind J Pharmacol 2013;45:429-33.
45. Ananthakrishnan N, Arora N. Is there need for a transformational change to overcome the current problems with postgraduate medical education in India? Natl Med J India2012;25:101-8.
46. De Sousa IC, De Lima David JP, Noblatlde A. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ 2013;77:80.
47. Sreekanth SK, Sreekanth D. Need and importance of drug information centers in Indian hospital system. Int J Med Health Prof Res 2015;2:9-16.
48. Gregory PJ, Jalloh MA, Abe AM, Hu J, Hein DJ. Characterization of complementary and alternative medicine related consultations in an academic drug information service. J Pharm Pract 2016;29:539-42.
49. Brosen K, Andersen SE. Editor in chief clinical pharmacology in Denmark. Basic Clin Pharmacol Toxicol 2016;119:523-32.
50. Ho K, Nguyen A, Selinger J. Technology enabled academic detailing: Computer mediated education between pharmacists and physicians for evidence based prescribing. Int J Med Inform 2013;82:762-71.
Statistics
72 Views | 150 Downloads
Citatons
How to Cite
P, T., M. K, P. K. ADUSUMILLI, and S. HARSHA C. “AN OVERVIEW OF DRUG INFORMATION CENTER – FUNCTIONS AND CHALLENGES IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 5, Mar. 2020, pp. 11-15, doi:10.22159/ajpcr.2020.v13i5.37052.
Section
Review Article(s)